Covid-19: Will the Oxford vaccine 'Covidshield' be affordable for people in India?|Oneindia News

The Covishield vaccine manufactured by the Serum Institute of India (SII) will be priced at ₹ 200 a vial after a price agreement was arrived at with the government, as sources suggest.

The first 100 million doses will be priced ₹ 200, and the initial amount to be supplied is expected to be 11 million doses.

The drug is expected to roll out of SII's Pune facilities Monday night or Tuesday morning.

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous Covaxin earlier this month.

The government plans to cover 300 million people in the first part of the programme in which health workers, frontline staff such as police and people over the age of 50 and those with co-morbidities will be vaccinated first.

#Covid-19 #CovidVaccine #OxfordVaccine